Evidence-based medicine is a concept whereby medical decisions are made based on objective studies and outcomes. It makes sense. Treatments should work in the real work, improving and extending lives and the quality of life.
Obamacare, however, is anything but ‘evidence-based’.
In fact, the Independent Payment Advisory Board (IPAB) and the local Accountable Care Organizations (ACOs) of the new healthcare law will make decisions based mostly (but not entirely) on politics, regional powerbrokers, and cost. If a drug or treatment ‘sort of’ works, and it costs a lot less, then peripheral issues of side effects, efficacy, and quality of care will take a back seat.
One of the most personal and important aspects of every patient’s life is his/her reliance on prescription drugs. Nowadays, the integrity of a medical doctor’s ability to maintain a faithful and private relationship with his patients is being compromised.
With little more than a phone call to an office nurse, prescriptions are being switched by pharmacists, who are rewarded financially for such behavior. New electronic platforms mandated under the new health care reform law also serve to coerce physicians away from certain medications in favor of less expensive (and often less effective) alternative generic drugs.